Retour aux projets

10901.1;4 PFLS-LS

Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events

Résumé

Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events

Textes supplémentaires

Abstract

Development of a clinically superior alternative to today's available coronary artery stents: Qvanteq's Qstent is based on a surface modification of 'bare metal stents' and is expected to accelerate in-growth, which is generally believed to minimize the early and also late adverse cardiac events (i.e. heart attacks) that are associated with today's available 'bare metal stents' as well as 'drug-eluting stents'.

Participants

Georg Noll

Kontaktperson

georg.noll@usz.ch

Universitätsspital Zürich Georg Noll Rämistrasse 100 Klinik für Kardiologie 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2010-07-31
Date de fin
2012-07-18
Coûts totaux approuvés
CHF 276135.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • P004 Biochemistry, Metabolism 100.0%